Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Efficacy and Safety of Local Infiltration of RF16001 for Injection for Analgesia After Total Hip Arthroplasty (THA) in a Multicenter, Randomized, Double-blind, Parallel, Positive and Placebo-controlled Phase Ⅲ Clinical Trial

NCT07872826 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.

NCT NCT07872826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07872826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Efficacy and Safety of Local Infiltration of RF16001 for Injection for Analgesia After Total Hip Arthroplasty (THA) in a Multicenter, Randomized, Double-blind, Parallel, Positive and Placebo-controlled Phase Ⅲ Clinical Trial
Lead sponsor
The Third Xiangya Hospital of Central South University
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
October 10, 2026
Completion date
October 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain after abdominal surgery